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Since their original description in 1970s,
huge steps forward have been made on the
knowledge of the biology of Natural Killer
lymphocytes (NK). Several evidences indi-
cate that NK could be considered as a
keystone in the immune system regula-
tion, indeed they bring together the innate
and adaptive immunity, branches of the
immune response.
Hitherto, adaptive immune response
has been classified according to three
main paradigms: the recombination of
specific gene for the receptor repertoire
(i.e., RAG1/2 gene expression for B cell
receptor (BCR) and T cell receptor (TCR),
the acquirement of specificity and immune
memory due to the interaction with anti-
gen processing cells (APC) in secondary
lymphoid organs, and the timing of action;
moreover, while innate immunity recep-
tors do not require gene rearrangement,
adaptive immunity is quickly acting and
have no immune memory.
In this context, the more orthodox
point of view separates, according to their
functions, the innate from the adaptive
immune responses. Nevertheless, several
data’s suggest a fine integration of the
two arms of immunity. This integration is
promoted by the interaction and involve-
ment of many cells “acting in concert” to
achieve the protection of “self” biological-
components. In this regard, it is worth
noting that NK cells can even work as
“adaptive effectors” once activated by the
IFN-γ produced by T cells or when the IgG
bounds to CD16 which eventually elicits
an antibody dependent cell cytotoxicity,
(ADCC) response (Lanier, 2005; Caligiuri,
2008; Vivier et al., 2008).
The common opinion is that innate
response discriminate the self from
non-self recognizing microbial prod-
ucts (such as bacterial or fungal LPS,
etc.). These components recognized by
germline encoded receptors as “non-
self,” are associated with pathogens.
Moreover, the adaptive immunity surveils
and preserves the integrity of the self,
recognizing a wide range of alterations
i.e., non-self allogeneic transplanted tis-
sues, self-altered tissues, which might be
altered either by virus or oncogene-derived
peptides. The adaptive cells recognize
MHC molecules by RAG1/2-dependent
receptors, TCR.
While the innate immunity plays a
crucial role in the first 48–72h of the
pathogenetic event, adaptive immune
surveillance requests longer time (weeks
or months) and the related immunolog-
ical memory could have no expiration
throughout life. This dichotomous view
can be unified whether one considers
that immunity is a complex of inte-
grated responses, finalistically linked for
the elimination of pathological intrud-
ers and the preservation/restoration
of the organism homeostasis. This
hypothesis may lead to many philo-
sophical implications, but also suggests
a different point of view in order to
understand the biology of those cells
that are necessary for the integra-
tion between the innate and acquired
responses. In such scenario, the recent
acquisition of knowledge about the func-
tions of NK spread new light on the
effects of these cells in the regulation
of the whole immune response and
their role in adaptive immune response
(Paust et al., 2010).
The aim of this opinion is to
focus the reader’s attention toward the
“holistic” regulatory effects of NK cell
in immune response: this feature of
the NK cell biology field is till now
neglected, but it is highly promising
for a fertile research and translational
applications.
THE NK RECEPTORS MULTICIPLITY
NK cells receptor repertoire shares features
with macrophages as the recognition of
PAMPs, Fc, and MIP1-alpha thanks to
TLR, CD16, and CCR5 (Lanier, 2005;
Caligiuri, 2008; Vivier et al., 2008).
Surprisingly, in the last decades NK cel-
lular programs were found to be reg-
ulated by MHC class I molecules in
a reciprocal way of the one used by
CD8+ CD3+ T cells via TCR recognition
(Kärre et al., 1986).
Intensive research in the 1990s clarified
the molecular basis of their regulation of
cytotoxic activities (Caligiuri, 2008), mak-
ing them a promising new tool for bio-
logical therapy in cancer (Ljunggren and
Malmberg, 2007; Velardi, 2012).
The presence of a multiplicity of recep-
tors, such as TLR, ancient lectin-like
receptors (CD94), (Lanier, 2005; Caligiuri,
2008; Vivier et al., 2008), KIRs (Vivier
and Anfossi, 2004; Lanier, 2005; Parham,
2005; Caligiuri, 2008; Vivier et al., 2008),
CD40, CD80, CD86 receptors (Carbone
et al., 1997, 1999; Martín-Fontecha et al.,
1999; Terrazzano et al., 2002), stress
inducible molecules receptors (Gleimer
and Parham, 2003) gave to NK cells a
high plasticity in their interaction with
several other immune system cell types.
These features already predict their func-
tional plasticity, making them hard to
classify as innate or adoptive immunity
cell type.
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MULTIPLE NK CELLS MEDIATED
INTERACTIONSWITHIN IMMUNITY
Since their discovery (Kiessling et al.,
1975), NK cells have been classified
as innate cytotoxic effectors recognizing
tumors and viral-infected cell targets using
classical cell cytotoxicity assays. Hitherto,
these kinds of experiments have been the
leitmotiv of the NK cells-related research.
In this regard, only in the recent past it has
been suggested a role for NK activity in the
regulation of the balance adaptive immu-
nity (Vivier and Anfossi, 2004; Lanier,
2005; Parham, 2005; Caligiuri, 2008; Vivier
et al., 2008). In spite of these achievements,
NK cells are holding peculiar immuno-
logical features which still are unknown.
On the other hand, their role in the
adoptive immune response regulation was
already described in the 1980s (Kuwano
et al., 1986; Tovar et al., 1986). Moreover,
the interaction between adaptive tumoral
response and NK cells is evident since
IgG2a is the key adoptive effector molecule
that triggers NK cells ADCC by CD16
engagement. The relevance of this adap-
tive NK activation pathway is witnessed
by the dominant role of CD16 NK recep-
tor that does not require co-stimulatory
signal by the other activating receptors
(Bryceson et al., 2009). NK cells have been
reported to interact with B cells (Procopio
et al., 1985; Wyatt and Dawson, 1991)
DC (Carbone et al., 1999, 2000; Ferlazzo
et al., 2002; Moretta, 2002) with T cells
(Ardolino et al., 2011), and with granulo-
cytes (Jaeger et al., 2012).
THE NK CELLS MEMORY REVEALED IN
PATHOLOGY
NK memory has been recently described
after viral infection by CMV in human
and mouse, HIV and hantavirus in human
(Salazar-Mather et al., 1998; Björkström
et al., 2011; Eller et al., 2011; Lopez-Vergès
et al., 2011). So far the life span of this
memory NK subset has not been inves-
tigated in detail. Nevertheless, for HIV
and CMV infected patients it is conceiv-
able retain that the NK cells memory can
last for years, far over the classical innate
immunity time window.
THE NK CELLS IN SECONDARY
LYMPHOID TISSUES
NK cells are in the lymph nodes, and
human CD56 bright NK cells have been
found to be activated by CD8+T-derived
IFN-γ; eventually these T-cell activated
NK prime DC maturations (Caligiuri,
2008). Murine NK cells are quickly
recruited in lymph nodes after T cells
immunization and they contribute to Th1
immune polarization (Martín-Fontecha
et al., 2004). Analysis by in vivo imaging
evidenced that NK cell, during leishmania
major infection, after FN-γ production,
could influence both the DC and T cells
adaptive activity (Bajénoff et al., 2006).
A recently described NK subset is able to
produce IL-22 and IL-17 and seems to be
involved in lymphoid tissue organogen-
esis, which was thus named “lymphoid
tissue inducer cells” (LTi) (Cupedo et al.,
2009). This original NK cell appears dif-
ferent from to classical NK (Crellin et al.,
2010) and it can develop in NK22 cell
subset described to play a major role in
regulating T and B mucosal immunity
(Cella et al., 2010). Therefore, NK cells
are present in secondary organs where
they play a regulatory role for the immune
response.
THE NK CELLS TOLERANCE
Despite the involvement of NK cells
in self-tolerance has been suggested in
autoimmunity disease, their role is still
controversial and not clearly understood
(Lunemann et al., 2009). NK cells appear
to either protect or increase autoim-
mune disease. In animal models, they
protect against autoimmunity in early
phase of inflammation, but they exac-
erbate autoimmune diseases when the
chronic inflammation is fully consoli-
dated (Bielekova et al., 2006). In par-
ticular, depletion of NK cell increases
autoimmune disease, whereas their adop-
tive transfer reduces the severity of the
disease (Ogasawara et al., 2003, 2004; Li
et al., 2005). In humans, predisposition
to several autoimmune diseases (Martin
et al., 2002; Luszczek et al., 2004; Momot
et al., 2004; Suzuki et al., 2004) has also
been associated to the expression of cer-
tain KIRs and HLA genes. In myelodys-
plastic syndromes, it has been suggested
a role for NK in the selection/expansion
of dysplastic clones (Ruggiero et al., 2009;
Terrazzano et al., 2012). Thus, in the
autoimmune diseases NK cells play a role
mainly as regulatory cells for aberrant and
detrimental immune response.
SHOULD NEW EXPERIMENTAL
APPROACHES in vitro AND in vivo BE
CONSIDERED?
In reason of what has been discussed, it
is conceivable to propose new approaches
for the understanding of NK biology.
The above reported considerations could
be empirically tested using experimental
design where NK cells are investigated in
concert with other immune cells.
In vitro
So far, the read out for NK activities
has been the study of cell-mediated
cytotoxicity, degranulation assays, or
IFN-γ production. This approach gives
sharp informations on the possible NK
cell programs, but does not explore univer-
sally the relevancy of NK cells in immune
response. In contrast, a “three cells” exper-
iment (i.e., NK/DC/T or B cells) could
help us finding out the ultimate effects of
NK cells regulation on immunity during
infectious disease or neoplastic disorder
(Terrazzano et al., 2007).
In vivo
Historically, monoclonal-mediated NK-
ablation by anti-NK1.1 and anti-Asialo
GM1mAbs together with the use of
murinemodels (i.e., SCID, NOD g γ-chain
ko) have greatly contributed to the def-
inition of NK functions. Nowadays, the
elegant opportunity offered by the flox-cre
inducible tissue specific genes regulation
lead to even more tight observation of NK
cells subsets associated receptors function
in pathological settings (Eckelhart et al.,
2011). However, NK cells regulation have
been seldom analysed and manipulated in
a global way. One possibility could be to
reverse the ongoing experimental strategy:
i.e., starting from reductionistic models
gamma chain NOD ko mice where it is
possible first to manipulate selectively NK
cells compartment and then adding by cell
transfer the other lymphocytes subsets.
CONCLUSION
Despite the initial description of NK cells
as lymphocytes of the innate response,
recent progress has pointed out a broader
role for these lymphocytes in immunity.
In adaptive immunity, the NK polarize the
activity of T lymphocytes, regulating also
the adaptive response. In this regard, it
is possible to speculate that the functions
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of NK cells have been developed not only
to represent a “first line defense” and to
generate the context of stimuli in innate
response useful to foster the later stages
of the specific response, but also to inte-
grate, polarize, and complete the immune
adaptive stages through an implementa-
tion of specific NK activities, such as the
cytokine secretion, the interaction with the
DC, the regulation of T-cell and B cells
priming and activation, and, finally, the
contribution to the “immunological mem-
ory.” These features make NK cells able
to perform functions traditionally ascribed
to the adaptive immunity. Therefore, NK
cells seem to violate the classical paradigm
that defines them just as innate immunity
effectors cells. Currently, NK biology offers
intriguing points of view to understand
the complexity of the immune response
architecture. In this sense, the blurring by
NK cells of the frontier between innate
and acquired immunity could provide new
perspectives for the acquisition of more
complete knowledge over the physiology
of immune system and for the obtaining
of immune-based therapeutical strategies.
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